A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1
SourceScience Translational Medicine, 12, 544, (2020), article eaaz5629
Article / Letter to editor
Display more detailsDisplay less details
Science Translational Medicine
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.